Prolactin as a tumour marker in cancer of the cervix

The aim of this study was to determine the possible usefulness of prolactin as a tumour marker in cancer of the cervix. Serum prolactin levels were measured using an enzyme linked immunosorbent assay in 105 women divided into malignant, pre-malignant and control groups. Elevated levels of prolactin...

Full description

Saved in:
Bibliographic Details
Published inJournal of obstetrics and gynaecology Vol. 18; no. 3; pp. 260 - 262
Main Authors Perumal, B G, Moodley, J, Pegoraro, R J
Format Journal Article
LanguageEnglish
Published England Informa UK Ltd 1998
Taylor & Francis
Taylor & Francis Ltd
Subjects
Cervical cancer
Gynecology
Hormones
Women
Online AccessGet full text

Cover

More Information
Summary:The aim of this study was to determine the possible usefulness of prolactin as a tumour marker in cancer of the cervix. Serum prolactin levels were measured using an enzyme linked immunosorbent assay in 105 women divided into malignant, pre-malignant and control groups. Elevated levels of prolactin were found in 42.9% of patients with malignant disease, 22.9% of controls and 14.2% of individuals with premalignant disease. The differences were not statistically significant. Although prolactin levels were found to be elevated in some patients with malignant disease of the cervix, further studies are needed to establish whether this is of clinical significance.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0144-3615
1364-6893
DOI:10.1080/01443619867452